Mesalazine (Mezavant)

Indications

Mild-to-moderately active UC, acute attacks and remission maintenance in adults and children. Some preparations are not licensed for use in children.

Contraindications

Blood clotting abormalities; pulmonary disease; salicylate hypersensitivity; pregnancy; hepatic impairment. Use with caution in elderly patients. Monitor breast-fed infants for diarrhoea. | Potential side effects: Joint pain; cough; diarrhoea; dizziness; fever; gastrointestinal discomfort; headache; low white blood cell count; nausea; skin reactions; vomiting

Preparations Available

Oral tablet/granules, rectal foam, enema, suppository

Quantity

Dose: Mezavant XL: Induction, 2.4 g ×1*; Maintenance, 2.4 g ×1

Sizes Available

1.2g tablet (60), £42.95

Price

1.2g tablet (60), £42.95

More on: Aminosalicylates